Skip to main content
Integrity IndexIntegrity Index
← Companies
COCP

Cocrystal Pharma, Inc.

Data as of Oct 14, 2026
COCP
CIK 1412486Pharmaceutical Preparations
Federal contracts since 2024
$498K
1 awards · latest Dec 12, 2025

Federal contracts

$498,199 in federal contract awards across 1 actions since January 2024, most recently Dec 12, 2025. Amounts are obligated values as reported to USAspending; modifications and de-obligations can be negative.

By agency

  • Department of Health and Human Services$498K1 award

Largest awards

DateAwardAmount
Dec 12, 2025
Department of Health and Human Services
DEVELOPMENT OF PAN-INFLUENZA INHIBITORS TARGETING THE PA ENDONUCLEASE FROM THE VIRAL REPLICATION COMPLEX
$498,199

Data: FEC (PAC contributions, Schedule A), Quiver Quantitative (congressional holdings, lobbying, contracts), Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to Cocrystal Pharma, Inc. through its SEC registration (CIK 1412486) and tickers COCP.

As of: contract actions through Dec 12, 2025. Snapshot rebuilt Oct 14, 2026.

Holdings values are estimates from disclosed ranges. PAC contributions cover the current and previous election cycle and count only gifts to sitting members' principal campaign committees, so leadership PACs and losing candidates are not included.